首页> 外文期刊>Romanian Journal of Morphology and Embryology >Intra-peritoneal chronic loculation in peritoneal dialysis patients - a new medical management approach
【24h】

Intra-peritoneal chronic loculation in peritoneal dialysis patients - a new medical management approach

机译:腹膜透析患者的腹​​膜内慢性定位-一种新的医学管理方法

获取原文
           

摘要

Peritoneal dialysis (PD) limitation as renal replacement therapy is mostly due to peritonitis and complications. Formation and persistence of intra-abdominal loculations is often under-diagnosed. Encapsulated peritoneal sclerosis (EPS) is a life-threatening complication, but malnutrition, recurrent peritonitis and early membrane failure are insidious enemies that need to be emphasized. It is important to highlight the persistence of intra-abdominal fluid collection after clinical resolution of peritonitis in PD patients and to indicate a new medical management approach for an early diagnosis. During five years, we selected PD peritonitis cases followed by a six months interval free of infections. Ninety-seven subjects were followed at six months and one year after the first peritonitis. Tomography had been performed to patients presenting a positive inflammatory state without a specific infectious cause. Subjects presenting documented localized fluid collection (31 cases) were divided into: drug-treated group and those undergoing laparoscopy by a new surgery technique (seven patients); a comparison regarding the clinical state and biohumoral parameters was assessed in both groups. The prevalence of intra-abdominal loculation following an apparent resolved peritonitis was high (31.9%). The cases undergoing laparoscopy presented a better evolution - improved clinical status (p=0.001), higher hemoglobin values (p=0.06), significant lower doses of erythropoietin requirement (p=0.03), improved dialysis adequacy (p=0.005) and inflammatory state. In cases with confirmed fluid encapsulated loculation, an active attitude (screening imaging protocol and laparoscopic exploration) appears to be mandatory, decreasing the risk of EPS, a serious complication which pathology and treatment are incompletely understood.
机译:腹膜透析(PD)的局限性是肾脏替代疗法,这主要是由于腹膜炎和并发症引起的。腹腔内定位的形成和持续性常常被诊断不足。囊状腹膜硬化症(EPS)是危及生命的并发症,但营养不良,复发性腹膜炎和早期膜衰竭是需要强调的隐患。重要的是要突出PD患者腹膜炎的临床解决后腹腔积液的持续存在,并指出一种用于早期诊断的新医学管理方法。在五年中,我们选择了PD腹膜炎病例,然后间隔六个月没有感染。第一次腹膜炎发生后六个月零一年,随访了97名受试者。对表现为阳性炎症状态且无特定感染原因的患者进行了断层扫描。呈现记录的局部液体收集的受试者(31例)分为:药物治疗组和通过新手术技术进行腹腔镜检查的受试者(7例);在两组中评估了临床状态和生物体液参数的比较。明显的腹膜炎解决后,腹腔内定位的发生率很高(31.9%)。进行腹腔镜检查的病例表现出更好的进展-临床状态改善(p = 0.001),血红蛋白值升高(p = 0.06),促红细胞生成素需求量明显降低(p = 0.03),透析充分性改善(p = 0.005)和炎症状态。在确诊的液体包封位置的情况下,必须采取积极的态度(筛查成像方案和腹腔镜探查),从而降低EPS的风险,这是对病理和治疗的不完全了解的严重并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号